Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2010

Open Access 01-12-2010 | Debate

Health economics: the start of clinical freedom

Authors: José Antonio Sacristán, María Costi, Amparo Valladares, Tatiana Dilla

Published in: BMC Health Services Research | Issue 1/2010

Login to get access

Abstract

Background

Since Professor Hampton announced the death of clinical freedom in 1983, the increasing influence of Evidence-based Medicine and Health Technology Assessment has contributed to augment the feeling that clinicians have a secondary role in the therapeutic decision-making process.

Discussion

This article constitutes a reflection on how clinicians may use the results of economic evaluations in their daily clinical practice, making decisions about cost-effectiveness on a case by case basis, and addressing both the patient's and society's needs. To that end, some illustrating examples are taken from the literature to show there are factors with great impact on cost-effectiveness results that can be easily identified and modified by clinicians.

Summary

The evolution of the discipline and the trend towards a tailored therapy suggest that health economics is not the end of clinical freedom but the start of it.
Literature
1.
Hampton JR: The end of clinical freedom. Br Med J (Clin Res Ed). 1983, 287 (6401): 1237-38. 10.1136/bmj.287.6401.1237.CrossRef
2.
Maynard A: Evidence-based medicine: an incomplete method for informing treatment choices. Lancet. 1997, 349 (9045): 126-28. 10.1016/S0140-6736(96)05153-7.CrossRefPubMed
3.
Maynard A: Developing the health care market. Economic J. 1991, 101: 1277-86. 10.2307/2234443.CrossRef
4.
Prosser LA, Stinnett AA, Goldman PA, Williams LW, Hunink MG, Goldman L, Weinstein MC: Cost-effectiveness of cholesterol-lowering therapies according to selected patient characteristics. Ann Intern Med. 2000, 132 (10): 769-79.CrossRefPubMed
5.
Cantor SB, Ganiats TG: Incremental cost-effectiveness analysis: the optimal strategy depends on the strategy set. J Clin Epidemiol. 1999, 52 (6): 517-22. 10.1016/S0895-4356(99)00021-9.CrossRefPubMed
6.
Earnshaw SR, Moride Y, Rochon S: Cost-effectiveness of pegaptanib compared to photodynamic therapy with verteporfin and to standard care in the treatment of subfoveal wet age-related macular degeneration in Canada. Clin Ther. 2007, 29 (9): 2096-106. 10.1016/j.clinthera.2007.09.001.CrossRefPubMed
7.
Clark WF, Churchill DN, Forwell L, Macdonald G, Foster S: To pay or not to pay? A decision and cost-utility analysis of angiotensin-converting-enzyme inhibitor therapy for diabetic nephropathy. CMAJ. 2000, 162 (2): 195-98.PubMedPubMedCentral
8.
Huang ES, Shook M, Jin L, Chin MH, Meltzer DO: The impact of patient preferences on the cost-effectiveness of intensive glucose control in older patients with new-onset diabetes. Diabetes Care. 2006, 29 (2): 259-64. 10.2337/diacare.29.02.06.dc05-1443.CrossRefPubMedPubMedCentral
9.
Lunshof J: Personalized medicine: how much can we afford? A bioethics perspective. Per Med. 2005, 2 (1): 43-47. 10.1517/17410541.2.1.43.CrossRef
Metadata
Title
Health economics: the start of clinical freedom
Authors
José Antonio Sacristán
María Costi
Amparo Valladares
Tatiana Dilla
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2010
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/1472-6963-10-183

Other articles of this Issue 1/2010

BMC Health Services Research 1/2010 Go to the issue

Study protocol

Physicians' social competence in the provision of care to persons living in poverty: research protocol

Research article

Development and preliminary validation of a questionnaire to measure satisfaction with home care in Greece: an exploratory factor analysis of polychoric correlations

Research article

What's the effect of the implementation of general practitioner cooperatives on caseload? Prospective intervention study on primary and secondary care

Research article

A cross-sectional prospective study of seclusion, restraint and involuntary medication in acute psychiatric wards: patient, staff and ward characteristics

Research article

A toolkit for incorporating genetics into mainstream medical services: Learning from service development pilots in England

Research article

The experience of living with chronic heart failure: a narrative review of qualitative studies